David Gómez‐Almaguer

5.7k total citations
335 papers, 3.0k citations indexed

About

David Gómez‐Almaguer is a scholar working on Hematology, Public Health, Environmental and Occupational Health and Genetics. According to data from OpenAlex, David Gómez‐Almaguer has authored 335 papers receiving a total of 3.0k indexed citations (citations by other indexed papers that have themselves been cited), including 229 papers in Hematology, 98 papers in Public Health, Environmental and Occupational Health and 81 papers in Genetics. Recurrent topics in David Gómez‐Almaguer's work include Hematopoietic Stem Cell Transplantation (120 papers), Acute Lymphoblastic Leukemia research (85 papers) and Acute Myeloid Leukemia Research (59 papers). David Gómez‐Almaguer is often cited by papers focused on Hematopoietic Stem Cell Transplantation (120 papers), Acute Lymphoblastic Leukemia research (85 papers) and Acute Myeloid Leukemia Research (59 papers). David Gómez‐Almaguer collaborates with scholars based in Mexico, United States and Brazil. David Gómez‐Almaguer's co-authors include José Carlos Jaime‐Pérez, Guillermo J. Ruíz‐Argüelles, Olga Graciela Cantú‐Rodríguez, Cesar Homero Gutiérrez‐Aguirre, Óscar González‐Llano, José Luís Herrera-Garza, Luz Tarín‐Arzaga, Andrés Gómez‐De León, Consuelo Mancías‐Guerra and Guillermo J. Ruiz‐Delgado and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

David Gómez‐Almaguer

293 papers receiving 3.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
David Gómez‐Almaguer Mexico 29 1.9k 741 700 579 523 335 3.0k
Guillermo J. Ruíz‐Argüelles Mexico 30 2.1k 1.1× 743 1.0× 599 0.9× 521 0.9× 411 0.8× 307 3.2k
Jeanne Palmer United States 30 2.0k 1.1× 561 0.8× 695 1.0× 605 1.0× 559 1.1× 153 2.9k
José Carlos Jaime‐Pérez Mexico 25 1.3k 0.7× 512 0.7× 472 0.7× 408 0.7× 365 0.7× 182 2.2k
Evarist Feliú Spain 30 1.3k 0.7× 721 1.0× 978 1.4× 682 1.2× 310 0.6× 209 3.0k
Jan‐Stephan Sanders Netherlands 34 1.8k 0.9× 528 0.7× 802 1.1× 848 1.5× 875 1.7× 168 4.2k
S Richards United Kingdom 25 1.0k 0.6× 1.2k 1.6× 434 0.6× 352 0.6× 335 0.6× 40 3.5k
A. Zander Germany 21 1.3k 0.7× 345 0.5× 453 0.6× 701 1.2× 263 0.5× 44 2.5k
Timothy J. Littlewood United Kingdom 29 2.4k 1.3× 239 0.3× 884 1.3× 802 1.4× 208 0.4× 61 3.2k
Prasad Mathew United States 28 1.3k 0.7× 325 0.4× 328 0.5× 501 0.9× 212 0.4× 90 3.0k
Antonio De Vivo Italy 35 1.9k 1.0× 271 0.4× 867 1.2× 930 1.6× 415 0.8× 90 3.9k

Countries citing papers authored by David Gómez‐Almaguer

Since Specialization
Citations

This map shows the geographic impact of David Gómez‐Almaguer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Gómez‐Almaguer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Gómez‐Almaguer more than expected).

Fields of papers citing papers by David Gómez‐Almaguer

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David Gómez‐Almaguer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Gómez‐Almaguer. The network helps show where David Gómez‐Almaguer may publish in the future.

Co-authorship network of co-authors of David Gómez‐Almaguer

This figure shows the co-authorship network connecting the top 25 collaborators of David Gómez‐Almaguer. A scholar is included among the top collaborators of David Gómez‐Almaguer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David Gómez‐Almaguer. David Gómez‐Almaguer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Colunga‐Pedraza, Perla R., et al.. (2024). Optimizing resources: low-dose nivolumab combinations in the management of relapsed/refractory Hodgkin lymphoma. Annals of Hematology. 103(12). 5607–5614. 2 indexed citations
3.
Colunga‐Pedraza, Perla R., Andrés Gómez‐De León, Luz Tarín‐Arzaga, et al.. (2024). Romiplostim, low‐dose rituximab and high‐dose dexamethasone for newly diagnosed immune thrombocytopenia: A pilot study. British Journal of Haematology. 208(2). 641–644.
4.
5.
6.
León, Andrés Gómez‐De, Irene García‐Cadenas, Perla R. Colunga‐Pedraza, et al.. (2024). Efficacy and Safety of Reduced-Doses of Post-Transplant Cyclophosphamide in Matched Peripheral Blood Stem Cell Transplantation, a Multicenter Study. Blood. 144(Supplement 1). 4898–4898.
7.
Colunga‐Pedraza, Perla R., et al.. (2022). Cytochrome P450 inhibition to decrease dosage and costs of venetoclax and ibrutinib: A proof‐of‐concept case study. British Journal of Clinical Pharmacology. 89(2). 898–902. 11 indexed citations
8.
León, Andrés Gómez‐De, et al.. (2021). Contributions to the American Society of Hematology Meeting From Low- and Middle-Income Countries: An In-Depth Analysis and Call to Action. JCO Global Oncology. 7(7). 622–631. 2 indexed citations
9.
Gómez‐Almaguer, David, et al.. (2020). The Leukoreductive Power of Vinblastine in Acute Myeloid Leukemia with Hyperleukocytosis: A Pilot Study. Blood. 136(Supplement 1). 35–36. 1 indexed citations
10.
Gutiérrez‐Aguirre, Cesar Homero, et al.. (2019). Dengue durante el embarazo, menor incidencia de trombocitopenia que en la población general. Revista de Salud Pública. 21(5). 1–6. 2 indexed citations
11.
Karduss, Amado, Robert Peter Gale, Cesar Homero Gutiérrez‐Aguirre, et al.. (2018). Freezing the graft is not necessary for autotransplants for plasma cell myeloma and lymphomas. Bone Marrow Transplantation. 53(4). 457–460. 23 indexed citations
12.
Jaime‐Pérez, José Carlos, David Gómez‐Almaguer, Rocío Ortiz‐López, et al.. (2016). Prevalence and Clinical Significance of FLT3 Mutation Status in Acute Myeloid Leukemia Patients: A Multicenter Study. Archives of Medical Research. 47(3). 172–179. 11 indexed citations
13.
Jaime‐Pérez, José Carlos, et al.. (2014). Sweet syndrome presenting late after non Hodgkin's lymphoma and dermatomyositis. Medicina Universitaria. 16(62). 25–27. 2 indexed citations
14.
Gutiérrez‐Aguirre, Cesar Homero, et al.. (2012). Síndrome de HELLP, diagnóstico y tratamiento. 13(4). 195–200. 4 indexed citations
15.
Gómez‐Almaguer, David, et al.. (2012). Utilidad del trasplante de células hematopoyéticas en la leucemia mieloide aguda. 13(2). 74–79.
16.
Cantú‐Rodríguez, Olga Graciela, Cesar Homero Gutiérrez‐Aguirre, José Carlos Jaime‐Pérez, et al.. (2011). Low incidence and severity of graft-versus-host disease after outpatient allogeneic peripheral blood stem cell transplantation employing a reduced-intensity conditioning. European Journal Of Haematology. 87(6). 521–530. 15 indexed citations
17.
Villarreal‐Pérez, Jesús Zacarías, David Gómez‐Almaguer, & Francisco Bosques‐Padilla. (2011). Errar es humano. Medicina Universitaria. 13(51). 69–71.
18.
Gómez‐Almaguer, David, et al.. (2010). Guías mexicanas de diagnóstico y recomendaciones terapéuticas para mieloma múltiple (2009). 11(1). 40–62. 3 indexed citations
19.
Vela‐Ojeda, Jorge, et al.. (2007). Autologous peripheral blood stem cell transplantation in multiple myeloma using oral versus I.V. melphalan. Annals of Hematology. 86(4). 277–282. 11 indexed citations
20.
Gómez‐Almaguer, David, Jorge Vela‐Ojeda, José Carlos Jaime‐Pérez, et al.. (2006). Allografting in patients with severe, refractory aplastic anemia using peripheral blood stem cells and a fludarabine-based conditioning regimen: The Mexican experience. American Journal of Hematology. 81(3). 157–161. 31 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Guillermo J. Ruíz‐Argüelles Breakdown of academic impact, for papers by Jeanne Palmer Breakdown of academic impact, for papers by José Carlos Jaime‐Pérez Breakdown of academic impact, for papers by Evarist Feliú Breakdown of academic impact, for papers by Jan‐Stephan Sanders Breakdown of academic impact, for papers by S Richards Breakdown of academic impact, for papers by A. Zander Breakdown of academic impact, for papers by Timothy J. Littlewood Breakdown of academic impact, for papers by Prasad Mathew Breakdown of academic impact, for papers by Antonio De Vivo
Rankless by CCL
2026